Oculogica Inc.

Oculogica Inc. is a woman-owned medical device company specializing in non-invasive eye-tracking diagnostic technology for objective concussion assessment. The flagship product, EyeBOX®, is FDA-cleared to aid in concussion diagnosis by measuring ocular motor abnormalities caused by cranial nerve impairment. The test is completed in under four minutes and delivers an objective "BOX score" within ten seconds, eliminating the need for baseline testing. Clinically validated through 16 peer-reviewed studies, EyeBOX® provides objective neurological assessment across patient ages 5–67 and is reimbursable. The technology serves sports medicine, veteran care, accident clinics, therapeutic clinics, and eye clinics. Oculogica's proprietary algorithms ensure diagnostic consistency across healthcare settings and improve communication between patients, families, and providers.